34th International Association of Surgeons, Gastroenterologists, and Oncologists (IASGO) World Congress

34th International Association of Surgeons, Gastroenterologists, and Oncologists (IASGO) World Congress, organized by the Triumph Group International, from Sep 09 - 12, 2023 at the Grand Guard Palace, Verona, Veneto, Italy.

Description:
This organization aims to spread medical knowledge and skills worldwide through a structured system of ongoing medical education. IASGO believes that everyone should have access to medical knowledge, regardless of individual, institutional, or national differences. This access is crucial for patients dealing with challenging and life-threatening illnesses.

We are currently experiencing an era of transition with significant innovations. Exciting scientific and technological advances are changing all areas of our lives. The recent emergency linked to the pandemic from COVID-19 has inevitably played the role of an accelerator by increasing society’s focus on health issues. As a result, new technologies and medical therapies are emerging for many diseases.

At the IASGO 2023, we will discuss recent developments in surgical oncology to improve patient care and quality standards. Molecular biology and biotechnology are also revolutionizing medicine. The management of cancers is changing through the characterization of tumor molecular biological profiles using next-generation sequencing. The future of medicine is increasingly taking shape with the latest discoveries in genetics that enable promising new directions in oncological therapies.

Understanding the specific disease in each cancer patient evoked a paradigm shift in oncology and is now opening new horizons in diagnostics and therapeutics. Progress is being made in the development of molecularly targeted therapy. Precision medicine aims to design and optimize the pathway for early diagnosis, assess prognosis, and tailor therapeutic interventions. Furthermore, artificial intelligence algorithms can now successfully predict the risk of cancers and gastrointestinal diseases.

More and more evidence suggests that lifestyle plays a fundamental role in well-being and patients’ health. Normal body weight and constant physical activity prevent gastrointestinal, metabolic, and neoplastic diseases and manage their presence. Likewise, proper nutrition counteracts chemotherapy’s side effects and helps faster recovery after surgery as demonstrated in the guidelines of the ERAS Society with which IASGO cooperates.

The newly established IASGO multidisciplinary clinical trials consortium for the treatment of oncological diseases seeks to improve diagnosis and increase treatment feasibility and efficacy. It also aims to make the available treatments more accessible, improves patients’ quality of life and compliance with therapies and follow-up, and thus optimize the use of resources.

Sustainability is becoming increasingly important in medicine and healthcare. Physicians need to be aware of eco-friendly solutions that provide high-quality care to patients while lowering costs and reducing environmental impact. Prevention, telemedicine counseling, training, and expanding healthcare coverage equitably should be the way forward.

We invite you to be part of the IASGO Congress from September 9th to 12th, 2023, at Palazzo Della Gran Guardia in Verona. This magnificent city, steeped in Italian history and globally renowned for its art and culture, is a UNESCO heritage site. Join us for the IASGO 34th World Congress in Verona, where we will celebrate the newest advancements in GI cancer treatment.

Main Topic:
• Advanced Imaging and Interventional Radiology
• Bariatric Surgery
• Circulating and tissue-based biomarkers
• Consortium for Multidisciplinary Clinical Studies in GI Diseases
• Digital healthcare and Artificial Intelligence
• Gastroenterology
• HPB (Surgery, Oncology and Endoscopic Intervention)
• Infection and Complications in surgery and oncology
• Inflammatory Bowel Diseases Management
• Laparoscopic and Robotic Surgery
• Liver Transplant (Oncological and non-oncological indications)
• Lower GI and Colorectal (Surgery, Oncology and Endoscopic Intervention)
• Molecular Pathology
• New Technology in Surgical Oncology
• Nuclear Medicine
• Nutrition and Lifestyle
• Organizational challenges and healthcare models
• Patients Advocacy
• Prevention of GI Diseases
• Radiotherapy
• Rare GI tumors (Neuroendocrine Tumors, GIST, and Sarcomas)
• Supportive and palliative care
• Targeted Therapy and Immunotherapy
• Transplant Surgery (Oncological and non-oncological indications)
• Upper GI (Surgery, Oncology and Endoscopic Intervention).